Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Operating Expenses: 2020-2023

Historic Operating Expenses for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $58.4 million.

  • Immuneering's Operating Expenses rose 16.56% to $16.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $58.4 million, marking a year-over-year increase of 12.54%. This contributed to the annual value of $58.4 million for FY2023, which is 12.54% up from last year.
  • Latest data reveals that Immuneering reported Operating Expenses of $58.4 million as of FY2023, which was up 12.54% from $51.9 million recorded in FY2022.
  • Immuneering's Operating Expenses' 5-year high stood at $58.4 million during FY2023, with a 5-year trough of $18.1 million in FY2020.
  • Over the past 3 years, Immuneering's median Operating Expenses value was $51.9 million (recorded in 2022), while the average stood at $48.4 million.
  • Data for Immuneering's Operating Expenses shows a peak YoY soared of 92.19% (in 2021) over the last 5 years.
  • Immuneering's Operating Expenses (Yearly) stood at $18.1 million in 2020, then surged by 92.19% to $34.8 million in 2021, then spiked by 49.09% to $51.9 million in 2022, then increased by 12.54% to $58.4 million in 2023.